![]()
Daily Range
Daily RangeToday's Low
₹ 28,725.00
Today's High
₹ 29,576.75
![]()
52 Weeks Range
52 Weeks Low
₹ 16,200.00
52 Weeks High
₹ 23,140.00
![]()
Momentum of the Stock
Momentum of the Stock ![]()
Bullish
Bullish![]()
Circuit Limit
Lower
₹ 26,047.75
Upper
₹ 31,836.10
![]()
Financials Strength Score
Financials Strength Score Piotroski Score
![]()
Company Profile
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, nutritional supplements, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
![]()
Companies under the same Group
Companies under the same Group
No Data Found
![]()
Key Metrics
Key MetricsStandalone
Consolidated
No of shares Outstanding
2.1 Cr.
EPS-TTM
₹0.00
Face Value
₹10.00
Book Value
₹0.00
Net Asset Value
₹81.86
ROE
37.45%
ROA
20.72%
ROCE
49.12%
Dividend Yield
1.42%
Total Debt
₹ 0.0 Cr.
Sales Growth
0.00%
PAT Growth
0.00%
Financials
| Particulars | FY 2001 |
|---|---|
| Total Current Assets | 101.2 |
| Total Non-Current Assets | 138.5 |
| Total Assets | 239.6 |
| Total Current Liabilities | 95.2 |
| Total Non-Current Liabilities | 11.8 |
| Shareholder's Funds | 132.6 |
| Total Liabilities | 239.6 |
![]()
Financial Statement Analysis
Quick Ratio
The Industry Quick Ratio stands at 1.77, vs the Quick Ratio of 0.00, which results in a Negative aspect.
Price to BV
The Industry Price to BV stands at 7.42, vs the Price to BV of 0.00, which results in a Negative aspect.
Debt to Equity Ratio
The Industry Debt to Equity Ratio stands at 0.21, vs the Debt to Equity Ratio of 0.00, which results in a Negative aspect.
Current Ratio
The Industry Current Ratio stands at 2.53, vs the Current Ratio of 0.00, which results in a Negative aspect.
| Particulars | FY 2001 |
|---|---|
| Total Income | 356.3 |
| Total Expenditure | 305.9 |
| Operating Profit(Excl OI) | 70.9 |
| Add: Other Income | 20.5 |
| Operating Profit | 70.9 |
| Less: Interest | 0.1 |
| PBDT | 70.8 |
| Less: Depreciation Amortization | 4.5 |
| PBT & Exceptional Items | 66.3 |
| Less: Exceptional Income Expenses | 0.0 |
| Profit Before Tax | 66.3 |
| Less: Taxation | 16.7 |
| Profit After Tax | 49.7 |
| Earnings Per Share | 0.0 |
![]()
Financial Statement Analysis
PAT Growth
The Industry PAT Growth stands at 38.69, vs the PAT Growth of 0.00, which results in a Negative aspect.
Dividend Yield
The Industry Dividend Yield stands at 0.54, vs the Dividend Yield of 0.00, which results in a Negative aspect.
PAT Margin
The Industry PAT Margin stands at 9.53, vs the PAT Margin of 0.00, which results in a Negative aspect.
PE Ratio
The Industry PE Ratio stands at 48.60, vs the PE Ratio of 0.00, which results in a Negative aspect.
| Particulars | FY 2001 |
|---|---|
| Profit Before Tax | 66.3 |
| Tax Paid | -14.6 |
| Adjustment | -2.3 |
| Changes In Working Capital | 66.3 |
| Cash Flow after changes in Working Capital | 50.1 |
| Cash Flow from Operating Activities | 35.5 |
| Cash Flow from Investing Activities | 0.6 |
| Cash Flow from Financing Activities | -27.0 |
| Net Cash Inflow / Outflow | 9.0 |
| Opening Cash & Cash Equivalents | 1.5 |
| Closing Cash & Cash Equivalent | 10.5 |
![]()
Financial Statement Analysis
PCF RATIO
The Industry PCF RATIO stands at 26.80, vs the PCF RATIO of 0.00, which results in a Negative aspect.
PFCF Ratio
The Industry PFCF Ratio stands at 37.13, vs the PFCF Ratio of 0.00, which results in a Negative aspect.
| Particulars | |
|---|---|
| Net Sales | - |
| Total Income | - |
| Total Expenditure | - |
| PBIDT (Excl OI) | - |
| Other Income | - |
| Operating Profit | - |
| Interest | - |
| Exceptional Items | - |
| PBDT | - |
| Depreciation | - |
| Profit Before Tax | - |
| Tax | - |
| Provisions and contingencies | - |
| Profit After Tax | - |
| Net Profit | - |
| ADDITIONAL INFOS: | |
| Equity Capital | - |
| Reserves | - |
| EPS | - |
| Operating Profit Margin | - |
| Net Profit Margin | - |
![]()
Financial Statement Analysis
Net Sales Growth
The Industry Net Sales Growth stands at 9.65, vs the Net Sales Growth of 0.00, which results in a Negative aspect.
Technicals
![]()
Pivot Levels
Pivot Levels Check Advanced Levels ![]()
| Type | Classic | Woodie | Camarilla |
|---|---|---|---|
| R4 | 30,645.45 | 31,601.66 | 29,410.41 |
| R3 | 30,289.22 | 30,219.57 | 29,176.18 |
| R2 | 29,932.98 | 29,898.16 | 29,098.10 |
| R1 | 29,437.47 | 29,367.82 | 29,020.03 |
| Pivot | 29,081.23 | 29,046.41 | 29,081.23 |
| S1 | 28,585.72 | 28,516.07 | 28,863.87 |
| S2 | 28,229.48 | 28,194.66 | 28,785.80 |
| S3 | 27,733.97 | 27,664.32 | 28,707.72 |
| S4 | 27,238.45 | 26,491.16 | 28,473.49 |
(All Values are in INR)
The Pivot level gives the user an indication about key support & resistance levels for a selected stock.
EMA & SMA Levels 
![]()
Beta
Beta 1 Day
0.37
1 Week
0.37
1 Month
0.39
![]()
Indicators
Stoch RSI
100.00
Bearish
RSI
63.44
Neutral
ROC
-0.48
Bearish
UltimateOscillator
58.56
Neutral
Williams Indicator
-23.98
Neutral
CCI Indicator
55.32
Neutral
MACD
17,265.18
Bullish
Stochastic Indicator
80.65
Neutral
ATR
706.43
Low Volatility
Corporate Actions
![]()
Corporate Actions - Board Meet
Corporate Actions - Board Meet | Ex-Date | Ratio | Record Date |
|---|
| Ex-Date | Ratio | Record Date |
|---|---|---|
| Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
|---|---|---|---|
| 21-07-2023 | 180.00 | 1800 | Final |
| 21-07-2023 | 145.00 | 1450 | Special |
| 02-08-2022 | 145.00 | 1450 | Final |
| 02-08-2022 | 130.00 | 1300 | Special |
| 19-07-2021 | 120.00 | 1200 | Final |
| 19-07-2021 | 155.00 | 1550 | Special |
| Date Of Conduct | Board Meeting Details |
|---|---|
| 05-02-2025 | Quarterly Results |
| 07-11-2024 | Quarterly Results |
| 01-02-2024 | Quarterly Results |
| 09-11-2023 | Quarterly Results |
| 09-08-2023 | Quarterly Results |
| 19-05-2023 | Final Dividend & Audited Results |
| 10-02-2023 | Quarterly Results |
| 14-11-2022 | Quarterly Results |
| 10-08-2022 | Quarterly Results |
| 17-05-2022 | Audited Results & Dividend |
| 09-02-2022 | Quarterly Results |
| 12-11-2021 | Quarterly Results |
| 06-08-2021 | Quarterly Results |
| 18-05-2021 | Final Dividend & Audited Results |